Randomized phase II study of interleukin-12 in combination with rituximab in patients with non-Hodgkin's lymphoma
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Interleukin-12 (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia; Follicular lymphoma; Mantle-cell lymphoma; Marginal-zone-B-cell-lymphoma; Non-Hodgkin's lymphoma; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 21 Dec 2012 Primary endpoints added as reported by ClinicalTrials.gov.
- 08 Mar 2008 Status changed from in progress to completed.
- 06 Oct 2005 New trial record.